Lychnopholide, a substance isolated from a Brazilian plant, and formulated as part of “nanocapsules” cured more than half of a group of mice that had been infected experimentally with Chagas disease parasites.
“Chagas disease affects millions of people, mainly in poor rural areas of 21 Latin American countries,” said Marta de Lana, PhD. The research is published in online ahead of print June 20 in Antimicrobial Agents and Chemotherapy, a journal of the American Society for Microbiology.
The new nanocapsules that constitute the delivery system for the lychnopholide in this study are a clever advance over the previous version. The previous–conventional–nanocapsules are recognized as foreign and attacked by host immune cells as they travel through the blood, before entering host cells, where the parasites lodge, said de Lana, who is Professor of Clinical Parasitology, in the School of Pharmacy, the Federal University of Ouro Preto, Minas Gerais, Brazil.
The new “stealth” nanocapsules are designed to go unrecognized by immune cells that patrol the blood. Once they enter host cells, they release the lychnopholide, killing the parasites,Trypanosome cruzi.
Another advantage of the stealth nanocapsules is that they can be taken orally, rather than intravenously, as they are impervious to the acidity and enzymes of the stomach. This is far more practical, especially in less developed countries.
Not surprisingly, the stealth nanocapsules are considerably more effective than the conventional nanocapsules. In the study, in the acute (early) phase of the disease, the stealth nanocapsules cured 62.5 percent of the mice, compared to 57.0 percent for the conventional nanocapsules. During the later chronic phase, the stealth and the conventional nanocapsules cured 55.6 percent and 30.0 percent of the mice, respectively.
“Both nanoencapsulated formulations are so simple that they may be produced in a simple laboratory,” said de Lana. Additionally, scale-up for commercial production would be simple, she said.
An estimated seven million people, mostly in Latin America, have Chagas disease, according to the World Health Organization. Up to one third develop cardiac abnormalities including enlarged heart, and arrhythmias, which can cause sudden death. As many as ten percent develop neurological and/or digestive problems. The main mechanism of spread is via triatomine insects, vectors that are known colloquially as kissing bugs, assassin bugs, or vampire bugs. Recently, the disease has spread to the United States and to several countries on other continents via other mechanisms.
No vaccines are available for Chagas. Treatment with conventional drugs–benznidazole or nifurtimox–is very effective at eradicating the parasites early in the disease’ acute phase. But efficacy falls off sharply with time. This is a problem because symptoms often take time to develop, and by the time they appear, the disease may be too far along to be cured using these drugs. Additionally, both drugs have harmful side effects.
The Latest on: Chagas disease
via Google News
The Latest on: Chagas disease
- Chagas Disease, Franceon January 2, 2021 at 4:00 pm
Chagas disease (CD) is endemic to Latin America; its prevalence is highest in Bolivia. CD is sometimes seen in the United States and Canada among migrants from Latin America, whereas it is rare in ...
- Chagas Disease Surveillance Activities — Seven States, 2017on December 25, 2020 at 4:00 pm
Chagas disease, a potentially life-threatening disease caused by the protozoan parasite Trypanosoma cruzi, has become a concern in the United States as a result of human emigration from Latin ...
- Scorpion Venom Helps Treat Chagas Diseaseon December 25, 2020 at 12:10 pm
VmCT1, the antimicrobial peptide isolated from the venom of the scorpion Vaejovis mexicanus killed Trypanosoma cruzi, the parasite that causes Chagas disease, said researchers at the Federal ...
- Enhanced scorpion venom molecules can be used to treat Chagas diseaseon December 21, 2020 at 11:53 am
Chagas is considered a neglected disease by the World Health Organization (WHO). It is endemic in several countries, affecting some 8 million people worldwide and killing around 10,000 per year.
- Chagas Diseaseon December 20, 2020 at 4:01 pm
A new study examines local perceptions of Chagas disease in a region where the infectious agent is endemic. The results underline the need to take social and cultural factors into account in ...
- A blood-sucking, face-biting bug is spreading through the USon December 18, 2020 at 11:58 am
While kissing bug bites aren't dangerous, the insect can transmit a parasite that causes a serious but treatable condition called Chagas disease. In July 2018, a Delaware family in Kent County ...
- Diseased Texan man survived on grasshoppers 1,000 years agoon December 17, 2020 at 6:44 am
They found the unfortunate man had Chagas disease, caused by parasites carried by insects, which resulted in him developing a 'megacolon'. Due to the intense pain, he was fed a diet of ...
- GHIT Fund Announces New Investments: A Total of 230 Million Yen in Drugs for Malaria and Chagas Diseaseon December 8, 2020 at 1:45 pm
"We are pleased to announce our new investments in innovative approaches to identify new drug targets and candidates in early-stage drug development for malaria and Chagas disease. We are very ...
- Metabolic State of a Parasite Influences Its Resistance to Drugson December 2, 2020 at 4:23 am
The study in cultures of human cells infected with Trypanosoma cruzi (T. cruzi), the parasite that causes Chagas disease, suggests that its metabolic state influences the effectiveness of azole drugs ...
via Bing News